Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Anemia and Alk[original query] |
---|
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar . Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark |
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib. Cancer management and research 2019 11 8191-8200. Liang Hongge, Ma Di, Xu Yan, Zhao Jing, Chen Minjiang, Liu Xiaoyan, Zhong Wei, Li Junling, Wang Mengzh |
Evaluation of the efficacy of PD?1/PD?L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene?negative advanced?stage lung adenocarcinoma: A retrospective cohort study. Oncology letters 2024 11 29 (1): 53. Xiaozun Yang, Xin Li, Ke Huang, Xiang Zhua |
- Page last reviewed:Feb 1, 2024
- Content source: